Citadel Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-21,316
| Closed | -$415K | – | 4863 |
|
|
2018
Q1 | $415K | Sell |
21,316
-33,581
| -61% | -$654K | ﹤0.01% | 3061 |
|
|
2017
Q4 | $914K | Sell |
54,897
-176,361
| -76% | -$2.94M | ﹤0.01% | 2443 |
|
|
2017
Q3 | $4.7M | Sell |
231,258
-1,953,355
| -89% | -$39.7M | ﹤0.01% | 1301 |
|
|
2017
Q2 | $35.2M | Buy |
2,184,613
+440,398
| +25% | +$7.09M | 0.03% | 408 |
|
|
2017
Q1 | $22.1M | Buy |
1,744,215
+1,534,509
| +732% | +$19.4M | 0.02% | 556 |
|
|
2016
Q4 | $2.78M | Sell |
209,706
-278,675
| -57% | -$3.69M | ﹤0.01% | 1339 |
|
|
2016
Q3 | $11.6M | Buy |
488,381
+225,949
| +86% | +$5.36M | 0.01% | 706 |
|
|
2016
Q2 | $7.56M | Sell |
262,432
-305,353
| -54% | -$8.8M | 0.01% | 835 |
|
|
2016
Q1 | $18.2M | Buy |
567,785
+183,333
| +48% | +$5.87M | 0.02% | 501 |
|
|
2015
Q4 | $16.4M | Buy |
384,452
+377,357
| +5,319% | +$16.1M | 0.02% | 666 |
|
|
2015
Q3 | $250K | Sell |
7,095
-257,643
| -97% | -$9.08M | ﹤0.01% | 3054 |
|
|
2015
Q2 | $12.2M | Buy |
264,738
+246,699
| +1,368% | +$11.3M | 0.01% | 902 |
|
|
2015
Q1 | $845K | Buy |
18,039
+8,843
| +96% | +$414K | ﹤0.01% | 2304 |
|
|
2014
Q4 | $292K | Sell |
9,196
-93,816
| -91% | -$2.98M | ﹤0.01% | 2872 |
|
|
2014
Q3 | $2.44M | Buy |
+103,012
| New | +$2.44M | ﹤0.01% | 1479 |
|
|
2014
Q2 | – | Sell |
-151,726
| Closed | -$4.01M | – | 3912 |
|
|
2014
Q1 | $4.01M | Sell |
151,726
-756,874
| -83% | -$20M | ﹤0.01% | 1170 |
|
|
2013
Q4 | $22.8M | Sell |
908,600
-514,591
| -36% | -$12.9M | 0.03% | 507 |
|
|
2013
Q3 | $29.2M | Sell |
1,423,191
-98,944
| -7% | -$2.03M | 0.04% | 399 |
|
|
2013
Q2 | $30.4M | Buy |
+1,522,135
| New | +$30.4M | 0.05% | 360 |
|